Xeplion 25 mg
Xeplion 25 mg is a medicine authorised by Swissmedic under authorisation number 60466. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 December 2010 and the authorisation is valid without a time limit. ATC code N05AX13 places the medicine in the group Psycholeptics.
| Authorisation number | 60466 |
|---|---|
| Name | Xeplion 25 mg |
| Full name | Xeplion 25 mg, Depot-Injektionssuspension in einer Fertigspritze |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05AX13 |
| First authorisation | 15 December 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Xeplion 25 mg, Depot-Injektionssuspension in einer Fertigspritze | B | 15 December 2010 |
| 2 | Xeplion 50 mg, Depot-Injektionssuspension in einer Fertigspritze | B | 15 December 2010 |
| 3 | Xeplion 75 mg, Depot-Injektionssuspension in einer Fertigspritze | B | 15 December 2010 |
| 4 | Xeplion 100 mg, Depot-Injektionssuspension in einer Fertigspritze | B | 15 December 2010 |
| 5 | Xeplion 150 mg, Depot-Injektionssuspension in einer Fertigspritze | B | 15 December 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | N05AX13 | 01.05.0. | B |
| 2 | 1 | Fertigspritze(n) | N05AX13 | 01.05.0. | B |
| 3 | 1 | Fertigspritze(n) | N05AX13 | 01.05.0. | B |
| 4 | 1 | Fertigspritze(n) | N05AX13 | 01.05.0. | B |
| 5 | 1 | Fertigspritze(n) | N05AX13 | 01.05.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Xeplion 25 mg authorised in Switzerland?
Yes. Xeplion 25 mg is authorised by Swissmedic under authorisation number 60466, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Xeplion 25 mg have?
Xeplion 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Xeplion 25 mg?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.